Skip to content

Clinical trials

Phase 2 Inflammation trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Phase: Phase 2 Country / region: Netherlands Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20082
20113
20161
20181
20191
20201
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting2
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Radboud University Medical Center2
AM-Pharma1
Amgen1
Center for Integrated Rehabilitation and Organ Failure Horn1
Centocor, Inc.1
Groningen Research Institute for Asthma and COPD1
InflaRx GmbH1
Leiden University Medical Center1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation14
Crohn Disease4
Pulmonary Disease, Chronic Obstructive3
Autoimmune Diseases1
Bacterial Infections and Mycoses1
Bronchitis, Chronic1
Cachexia1
Diabetes Mellitus1
Granuloma1
Hidradenitis Suppurativa1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.